Aims & Scope

Aims

COVID (ISSN 2673-8112) is an open access journal that provides an advanced and multidisciplinary forum for the study of coronaviruses, coronavirus-related diseases and global impact. Our aim is to publish papers on all aspects of coronaviruses, from basic molecular and clinical research to COVID-related public health studies, physical and psychological health, economic and environmental impact and all other aspects affected by coronaviruses.

We welcome the submission of original research articles, reviews that are not part of Special Issues, communications, brief reports and several other types of papers. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The full experimental details must be provided so that the results can be reproduced. Large electronic files, software, movies, etc., that cannot be published in the main paper can be posted as supplementary material.

Scope

• Human or Animal Coronaviruses: epidemiology and evolution; viral cross-species transmission and evolution; viral host interactions; mechanistic studies on coronaviruses; and pre-clinical studies on cellular and animal models.
• Clinical Treatment: viral respiratory infection; coronavirus pneumonia; severe acute respiratory syndrome; Middle East respiratory syndrome; and coronavirus immunity.
• Treatment Development: vaccine design; therapeutic vaccines; antiviral drug design; monoclonal antibodies; peptides; assay development and test kits; diagnostics; combinatorial therapies; and advances in cell as well as gene therapies.
• Public Health: pandemic surveillance; epidemiologic models; dynamic models; social and physical effects of lockdowns; mental health; vaccination campaigns; pandemic-related retrospective studies; and work engagement.
• Healthcare and COVID Complications: ventilation and transmission; acute respiratory failure; pneumonia; acute respiratory distress syndrome; acute liver injury; acute cardiac injury; cardiovascular risk factors; secondary infection; acute kidney injury; septic shock; comorbidities; and nursing perspectives.
• Global Impact: economic impact; lifestyle changes; online education; tourism; environmental impact; food supply; and logistics.
• Host Genetics and Susceptibility/Resistance: epidemiological and experimental evidence; predisposition; monogenic and polygenic inheritance; errors of immunity; and interferonopathies.

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in COVID will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact publisher@mdpi.com for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is covid@mdpi.com.